Management

NNE has a two-tier structure: the Board of Directors and NNE Management. The Board of Directors supervise the performance, management and organisation of our company and are elected every year at the Annual General Meeting. They consist of three representatives from our parent company, Novo Nordisk, and two employee representatives. NNE Management is responsible for our daily operations.

NNE Management

Jesper Kløve

Chief Executive Officer

Christoffer Hviid

Chief Financial Officer

Steen Kristensen

Corporate Vice President, Project Execution

Marianne Regin Palme

Vice President, Sales, Front-End & Innovation

Lotte Vistisen

Corporate Vice President, Process & Facility Design

Peter Engdal Sørensen

Vice President, Project Management

Thomas Sichmann

Corporate Vice President, Automation & IT

Silas Egelund Volfing

Corporate Vice President, Human Ressources

Sameer Taneja

General Manager, India

Jesper Bech

General Manager, US

Karsten Munk Knudsen

Chairman of the NNE Board since 2017

Born in 1971. Executive Vice President and CFO at Novo Nordisk A/S and has held various positions in Novo Nordisk since 1999. Member of the Board of Directors of Hempel A/S and of 3Shape Holding A/S.

Michael Hallgren

Member of the NNE Board since 2018

Born in 1966. Senior Vice President at Novo Nordisk A/S and has held various positions in Novo Nordisk since 1994. President of the Board of Kalundborg Symbiosis.

Jesper Schufri Meyer

Employee-elected member of the NNE Board since 2023

Born in 1959. Senior Project Manager in Design Management and has held various positions in NNE since 2001. Currently, Jesper is the Senior Project Manager in our Design Management department. 

Inés Aréizaga Esteva

Employee-elected member of the NNE Board since 2021

Born in 1981. Senior Engineering Manager in Active Products and has held various positions in NNE since 2006. Currently, Inés is Manager in our Active Products department.

Jan Hoff

Member of the NNE Board since 2024

Born in 1975. CVP Novo Nordisk Consultant. Joined Novo Nordisk in 2005. As a leader in Product Supply, he has been responsible for multiple large-scale investment projects executed in partnership with NNE.

Corporate governance

 

NNE A/S is 100% owned by Novo Nordisk A/S and is included in the Consolidated Financial Statements of Novo Nordisk A/S.